Status: Recruiting
Orthobiological Therapies in Musculoskeletal Disorders
To evaluate the clinical and functional effects of using orthobiological therapies (hyaluronic acid, platelet-rich plasma, bone marrow aspirate, nanofat, among others) in the treatment of various musculoskeletal diseases in patients routinely treated at the Proregen Medical Clinic and its affiliates. The sample will consist of adult patients (≥18 years), of both sexes, with different musculoskeletal diagnoses involving joints, tendons, ligaments, cartilage or bone, among others.
Participants needed: 300
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: PROREGENUpdated: Sep 17, 2026Locations: 1
Eligibility criteria
Age 18 or older; [+4]
Medical contraindication to the use of orthobiologics (e.g., active infection, s... [+4]